Genetic biomarkers could personalise therapy for TNBC
Drug Discovery World
AUGUST 16, 2023
Triple negative cancers are not driven by any of the three molecules that can be blocked by targeted hormone receptor drugs – the HER2 protein and two hormone receptors for oestrogen and progesterone – and so current treatment options are limited.
Let's personalize your content